Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
11 août 2022 06h45 HE | Cingulate Inc.
$5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage...